Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
JAAD Case Rep ; 49: 132-134, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-39040158
3.
Skin Health Dis ; 4(1): e297, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38312258

RESUMEN

Hyper-IgE (HIES) is a rare, primary immunodeficiency characterised by eczema, recurrent staphylococcal infections, pneumonia, increased serum IgE and eosinophilia. We present the case of an 11-year-old girl presenting to dermatology with an acneiform facial rash and associated bacterial lymphadenitis. History was significant for otitis media, primary tooth retention, low impact wrist fracture, infantile acne and an absence of eczema or pneumonia. Investigations demonstrated mildly elevated IgE, normal eosinophils but positivity for a STAT3 gene mutation-thus representing a case of HIES presenting as an acneiform facial rash with absence of other primary immunological features.

4.
5.
Skin Health Dis ; 3(6): e279, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-38047255

RESUMEN

Case report of Morphoea induced by the use of electronic cigarettes.

6.
BMJ Case Rep ; 16(8)2023 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-37597858

RESUMEN

Amelanotic melanoma is an uncommon form of melanoma; accounting for 2%-8% of all melanoma cases. In the human population, the incidence of melanoma in patients with trisomy 21 is relatively unknown. It is theorised that having an extra copy of chromosome 21 is protective against melanoma development as people with trisomy 21 also carry an extra copy of the genes on that chromosome including any that protect against cancer. A literature review revealed four other reported cases of cutaneous melanoma in persons with trisomy 21. To the authors' knowledge, this is the first case of amelanotic melanoma presenting in a patient with trisomy 21 and the fifth case of melanoma overall reported in a patient with trisomy 21.This case highlights the need for specialist referral of all new skin lesions where the diagnosis is unclear.


Asunto(s)
Síndrome de Down , Melanoma Amelanótico , Neoplasias Cutáneas , Humanos , Síndrome de Down/complicaciones , Neoplasias Cutáneas/genética , Melanoma Amelanótico/diagnóstico , Pacientes , Melanoma Cutáneo Maligno
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA